Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples

Journal of Virological Methods

Volumn 180, Issue 1-2, 2012, Pages 7-10

  Martínez, Samuel Bernal ^a   Palomares, José Carlos ^a   Artura, Antonio ^a   Parra, Manuel ^a   Cabezas, Jose Luis ^a   Romo, Jose Ma ^a   Martín Mazuelos, Estrella ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

HPV 16; HPV 18; Human papillomavirus

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS IDENTIFICATION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 84857064112     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.12.002     Document Type: Article

References (13)

1. Castle P.E., Rodríguez A.C., Burk R.D., Herrero R., Wacholder S., Alfaro M., Morales J., Guillen D., Sherman M.E., Solomon D., Schiffman M. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 2009, 339:b2569.
2. Castle P.E., Sadorra M., Lau T., Aldrich C., García F.R.A., Kornegay J. Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotyping 16 (HPV 16) and HPV 18 genotyping. J. Clin. Microbiol. 2009, 47:3344-3347.
3. Cortes J., Martinón-Torres F., Ramon y Cajal J.M., Gil A., Velasco J., Abizanda M., Miranda P., Garrido P. Prevención primaria y secundaria de los canceres de cuello de útero y vulva: recomendaciones para la práctica clínica. Progresos de obstetricia y gineología 2010, 53(Suppl. 1):1-19.
4. De Sanjosé S., Díaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., Bosch F.X. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect. Dis. 2007, 7:453-459.
5. De Sanjosé S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B., Tous S., Felix A., Bravo L.E., Shin H.R., Vallejos C.S., de Ruiz P.A., Lima M.A., Guimera N., Clavero O., Alejo M., Llombart-Bosch A., Cheng-Yang C., Tatti S.A., Kasamatsu E., Iljazovic E., Odida M., Prado R., Seoud M., Grce M., Usubutun A., Jain A., Suarez G.A., Lombardi L.E., Banjo A., Menéndez C., Domingo E.J., Velasco J., Nessa A., Chichareon S.C., Qiao Y.L., Lerma E., Garland S.M., Sasagawa T., Ferrera A., Hammouda D., Mariani L., Pelayo A., Steiner I., Oliva E., Meijer C.J., Al-Jassar W.F., Cruz E., Wright T.C., Puras A., Llave C.L., Tzardi M., Agorastos T., Garcia-Barriola V., Clavel C., Ordi J., Andújar M., Castellsagué X., Sánchez G.I., Nowakowski A.M., Bornstein J., Muñoz N., Bosch F.X. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010, 1048-1056.
6. Kahn M.J., Castle P.E., Lorinncz A.T., Wacholder S., Sherman M., Scott D.R., Rush B.B., Glass A.G., Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility type-specific HPV testing in clinical practice. J. Natl. Cancer Inst. 2005, 97:1072-1079.
7. Mateos M.L., Chacón de Antonio J., Rodríguez-Domínguez M., Sanz I., Rubio M.D. Evaluación de un sistema de PCR a tiempo real (Cobas 4800) para la detección separada de los genotipos 16 y 18 y otros genotipos de alto riesgo del virus del papiloma humano en la prevención del cancer cervical. Enferm. Infecc. Microbiol. Clin. 2011, 10.1016/j.eimc.2011.01.007.
8. Mo L.Z., Monnier-Benoit S., Kantelip B., Petitjean A., Riethmuller D., Pretet J.L., Mougin C. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA genotyping assay to screen the discordant results. J. Clin. Virol. 2008, 41:104-110.
9. Molijn A., Kleter B., Quint W., Van Doorn L.J. Molecular diagnosis of human papillomavirus (HPV) infections. J. Clin. Virol. 2005, 32(Suppl. 1):S43-S51.
10. Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
11. Safaeian M., Schiffman M., Gage J., Solomon D., Wheeler C.M., Castle P.E. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res. 2009, 69:3262-3266.
12. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., Raab S., Sherman M., Wilbur D., Wright T., Young N. Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119.
13. Stoler M.H., Wright T., Sharma A., Apple R., Gutekinst K., Wright T. High-Risk human papillomavirus testing in women with ASC-US cytology. Am. J. Clin. Pathol. 2011, 135:468-475. the ATHENA HPV Study Group.